In conclusion, while ample evidence exists supporting TMEM16A's involvement in the initiation and progression of prostate cancer, the inconsistencies surrounding its specific mechanisms and prognostic implications underscore the need for further research. This evidence concerns the gene ANO1 and prostate cancer.